Sathya Elumalai

Sathya Elumalai
Co-founder and CEO
Multisensor Diagnostics

Sathya Elumalai is the Co-founder and CEO for Multisensor Diagnostics (MDX) with over fourteen years of experience in healthcare. He is a certified professional in healthcare quality and safety, and a formally trained health services researcher with diverse leadership experience in the areas of patient safety and quality outcomes at the Johns Hopkins Medical Institute. At MDx, Mr. Elumalai was at the forefront of developing a rapid medical assessment device, MouthLab, that non-invasively measures more than 10 vital health parameters in 30 seconds for monitoring and managing chronic disease patients at home.

In addition to his efforts at MDx, Mr. Elumalai also serves as an Advisory Board Member for Rutgers University, and an Ambassador and Merit Reviewer at Patient Centered Outcome Research Institute. Mr. Elumalai has demonstrated expertise serving in corporate leadership positions in organization-wide operational oversight roles for developing infrastructure and strategic initiatives resulting in increased profitability.

Mr. Elumalai holds a dual master’s degree, MS and MBA in Healthcare Management, from the prestigious Johns Hopkins University. He is also a proven leader recognized for building scalable processes, integrating analytics into decision making, improving customer satisfaction, and driving exceptional cross-functional integration and performance. With an entrepreneurial mindset supported by strong business acumen and educational qualifications in the Business of Medicine, Mr. Elumalai aims to manage large-scale healthcare transformations and implement innovations in the healthcare industry.

Recent Events and Presentations

April 24, 2018

Please join ITIF and the Center for the Protection of Intellectual Property for an event releasing a new report that documents 25 cases of primarily developing-world entrepreneurs meeting global health challenges by “innovating for health.” The event will discuss what policies, including intellectual property, are needed to underpin successful life-sciences innovation in both the developed and developing world and feature presentations from several developing-country healthcare innovators who are leveraging IP, science, and technology to create a better world.